[Form 4] Vuzix Corp Insider Trading Activity
Alasdair MacKinnon, a director of Vuzix Corp (VUZI), was granted 65,295 shares of restricted common stock on 08/05/2025.
Rhea-AI Filing Summary
Alasdair MacKinnon, a director of Vuzix Corp (VUZI), was granted 65,295 shares of restricted common stock on 08/05/2025. The Form 4 reports the acquisition at a reported price of $0, indicating a restricted stock grant rather than a market purchase. Following the grant MacKinnon beneficially owns 65,295 shares directly. The grant vests in three tranches: 45,295 shares vest on June 30, 2026, 10,000 shares vest on June 30, 2026, and 10,000 shares vest on June 30, 2027. The Form 4 is signed by MacKinnon on 09/25/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director received a restricted stock grant of 65,295 shares with staggered vesting, a routine equity compensation event.
The Form 4 shows an acquisition coded A(1) for 65,295 shares at $0, consistent with a restricted stock award rather than an open-market purchase. The grant vests mainly on June 30, 2026 with a smaller tranche in 2027, which provides short-term and medium-term alignment of the director with shareholder interests. The filing does not disclose any change to cash compensation, size of company-wide equity plans, or percent ownership relative to outstanding shares, so material impact on valuation cannot be assessed from this filing alone.
TL;DR: This is a standard director equity award with defined vesting dates, signaling alignment but not a material governance event.
The entry identifies MacKinnon as a director and reports direct beneficial ownership post-grant of 65,295 shares. The use of restricted stock with explicit vesting dates is a common governance practice to retain board members and align incentives. The Form 4 lacks details on grant authorization, plan source, or any performance conditions, so assessment of governance implications is limited to the observable vesting schedule and direct ownership reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 65,295 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents grant of restricted stock. 45,295 shares will vest on June 30, 2026, 10,000 shares will vest on June 30, 2026 and 10,000 shares will vest on June 30, 2027
AI-generated analysis. How Rhea-AI works. Not financial advice.